Overview

A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's Lymphoma

Status:
Withdrawn
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
A pharmacokinetic study to access how the body absorbs and removes ABT-199 in adults with Non-Hodgkin's Lymphoma.
Phase:
Phase 1
Details
Lead Sponsor:
AbbVie
Collaborator:
Genentech, Inc.
Treatments:
Venetoclax